Beam Therapeuticsinc Stock Today
| BEAM Stock | USD 24.31 1.39 5.41% |
Performance1 of 100
| Odds Of DistressLess than 10
|
Beam TherapeuticsInc is selling at 24.31 as of the 19th of April 2024; that is -5.41 percent decrease since the beginning of the trading day. The stock's lowest day price was 24.14. Beam TherapeuticsInc has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Beam TherapeuticsInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of February 2020 | Category Healthcare | Classification Health Care |
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Beam Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 81.66 M outstanding shares of which 13.45 M shares are currently shorted by private and institutional investors with about 10.67 trading days to cover. More on Beam TherapeuticsInc
Moving together with Beam Stock
| 0.85 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
| 0.67 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.72 | JSPRW | Jasper Therapeutics | PairCorr |
Moving against Beam Stock
| 0.51 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.5 | MRKR | Marker Therapeutics | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 8th of May 2024
Beam Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Beam TherapeuticsInc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Beam TherapeuticsInc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Beam TherapeuticsInc report their recommendations after researching Beam TherapeuticsInc's financial statements, talking to executives and customers, or listening in on Beam TherapeuticsInc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Beam TherapeuticsInc. The Beam consensus assessment is calculated by taking the average forecast from all of the analysts covering Beam TherapeuticsInc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Beam TherapeuticsInc's historical financial statements, Beam TherapeuticsInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Beam TherapeuticsInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beam TherapeuticsInc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Beam TherapeuticsInc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Beam TherapeuticsInc's financial leverage. It provides some insight into what part of Beam TherapeuticsInc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beam TherapeuticsInc (BEAM) is traded on NASDAQ Exchange in USA. It is located in 238 Main Street, Cambridge, MA, United States, 02142-1016 and employs 436 people. Beam TherapeuticsInc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Beam TherapeuticsInc's market, we take the total number of its shares issued and multiply it by Beam TherapeuticsInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Beam TherapeuticsInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 81.66 M outstanding shares of which 13.45 M shares are currently shorted by private and institutional investors with about 10.67 trading days to cover.
Beam TherapeuticsInc currently holds about 1.09 B in cash with (149.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.9.
Check Beam TherapeuticsInc Probability Of Bankruptcy
Ownership AllocationBeam TherapeuticsInc holds a total of 81.66 Million outstanding shares. The majority of Beam TherapeuticsInc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Beam TherapeuticsInc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Beam TherapeuticsInc. Please pay attention to any change in the institutional holdings of Beam TherapeuticsInc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Beam Ownership Details
Beam Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Beam TherapeuticsInc jumping above the current price in 90 days from now is about 90.06%. The Beam TherapeuticsInc probability density function shows the probability of Beam TherapeuticsInc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Beam TherapeuticsInc has a beta of -1.1136 suggesting Additionally, beam TherapeuticsInc has an alpha of 0.1311, implying that it can generate a 0.13 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Beam TherapeuticsInc to move above the current price in 90 days from now is about 90.06 (This Beam TherapeuticsInc probability density function shows the probability of Beam Stock to fall within a particular range of prices over 90 days) .
Beam Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Beam TherapeuticsInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Beam TherapeuticsInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Beam TherapeuticsInc's value.| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2023-12-31 | 1.6 M | |
| Redmile Group, Llc | 2023-09-30 | 1.5 M | |
| Citadel Advisors Llc | 2023-09-30 | 1.2 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 968.3 K | |
| Yiheng Capital Llc | 2023-12-31 | 845.5 K | |
| Sc China Holding Ltd | 2023-09-30 | 796.1 K | |
| Baillie Gifford & Co Limited. | 2023-12-31 | 764.1 K | |
| Bellevue Group Ag | 2023-12-31 | 694.8 K | |
| Northern Trust Corp | 2023-12-31 | 668.5 K | |
| Ark Investment Management Llc | 2023-12-31 | 9.4 M | |
| Vanguard Group Inc | 2023-12-31 | 7.2 M |
Beam TherapeuticsInc Historical Income Statement
Beam TherapeuticsInc Income Statement is one of the three primary financial statements used for reporting Beam's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Beam TherapeuticsInc revenue and expense. Beam TherapeuticsInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Beam TherapeuticsInc's Total Other Income Expense Net is very stable compared to the past year. As of the 19th of April 2024, Income Tax Expense is likely to grow to about 1.4 M, while EBIT is likely to drop (185.3 M). View More FundamentalsBeam Stock Against Markets
Picking the right benchmark for Beam TherapeuticsInc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Beam TherapeuticsInc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Beam TherapeuticsInc is critical whether you are bullish or bearish towards Beam TherapeuticsInc at a given time. Please also check how Beam TherapeuticsInc's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beam TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Beam TherapeuticsInc Corporate Management
Elected by the shareholders, the Beam TherapeuticsInc's board of directors comprises two types of representatives: Beam TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Beam. The board's role is to monitor Beam TherapeuticsInc's management team and ensure that shareholders' interests are well served. Beam TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Beam TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Liu | CoFounder | Profile | |
| Manmohan Singh | Chief Officer | Profile | |
| Feng Zhang | CoFounder | Profile | |
| Nicole Gaudelli | CoFounder | Profile | |
| Brian Riley | VP Operations | Profile | |
| John MBA | CEO Director | Profile | |
| Alexis Komor | CoFounder | Profile |
How to buy Beam Stock?
Before investing in Beam TherapeuticsInc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Beam TherapeuticsInc. To buy Beam TherapeuticsInc stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Beam TherapeuticsInc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Beam TherapeuticsInc stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Beam TherapeuticsInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Beam TherapeuticsInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Beam TherapeuticsInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Beam Stock please use our How to Invest in Beam TherapeuticsInc guide.
Already Invested in Beam TherapeuticsInc?
The danger of trading Beam TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Beam TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Beam TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Beam TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Beam TherapeuticsInc is a strong investment it is important to analyze Beam TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beam TherapeuticsInc's future performance. For an informed investment choice regarding Beam Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam TherapeuticsInc guide.Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Beam Stock analysis
When running Beam TherapeuticsInc's price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share 4.896 | Quarterly Revenue Growth 14.78 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.